Global Pharmacokinetic Testing Market Growth (Status and Outlook) 2026-2032

September 2026 | 97 pages | ID: GEFA026257F4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Pharmacokinetic Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Pharmacokinetic Testing Industry Forecast” looks at past sales and reviews total world Pharmacokinetic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmacokinetic Testing sales for 2026 through 2032. With Pharmacokinetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacokinetic Testing industry.

This Insight Report provides a comprehensive analysis of the global Pharmacokinetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmacokinetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacokinetic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacokinetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacokinetic Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacokinetic Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

  • Oral Dissolution Testing (FDC)
  • Intravenous Titration Test (IVRT)
  • Cell Line In-house Testing (ICR)

Segmentation by Application:

  • Hospital
  • Clinic
  • Research Institutions

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • Certara, L.P.
  • Evotec AG
  • Pacific BioLabs
  • GVK Biosciences Private Limited
  • SGS SA
  • LGC Limited
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pharmacokinetic Testing Market Size (2021-2032)
  2.1.2 Pharmacokinetic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Pharmacokinetic Testing by Country/Region (2021, 2025 & 2032)
2.2 Pharmacokinetic Testing Segment by Type
  2.2.1 Oral Dissolution Testing (FDC)
  2.2.2 Intravenous Titration Test (IVRT)
  2.2.3 Cell Line In-house Testing (ICR)
  2.2.4 Pharmacokinetic Testing Market Size by Type
    2.2.4.1 Pharmacokinetic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Pharmacokinetic Testing Market Size Market Share by Type (2021-2026)
2.3 Pharmacokinetic Testing Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Research Institutions
  2.3.4 Pharmacokinetic Testing Market Size by Application
    2.3.4.1 Pharmacokinetic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Pharmacokinetic Testing Market Size Market Share by Application (2021-2026)

3 PHARMACOKINETIC TESTING MARKET SIZE BY PLAYER

3.1 Pharmacokinetic Testing Market Size Market Share by Player
  3.1.1 Global Pharmacokinetic Testing Revenue by Player (2021-2026)
  3.1.2 Global Pharmacokinetic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Pharmacokinetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHARMACOKINETIC TESTING BY REGION

4.1 Pharmacokinetic Testing Market Size by Region (2021-2026)
4.2 Global Pharmacokinetic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmacokinetic Testing Market Size Growth (2021-2026)
4.4 APAC Pharmacokinetic Testing Market Size Growth (2021-2026)
4.5 Europe Pharmacokinetic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Pharmacokinetic Testing Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Pharmacokinetic Testing Market Size by Country (2021-2026)
5.2 Americas Pharmacokinetic Testing Market Size by Type (2021-2026)
5.3 Americas Pharmacokinetic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pharmacokinetic Testing Market Size by Region (2021-2026)
6.2 APAC Pharmacokinetic Testing Market Size by Type (2021-2026)
6.3 APAC Pharmacokinetic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pharmacokinetic Testing Market Size by Country (2021-2026)
7.2 Europe Pharmacokinetic Testing Market Size by Type (2021-2026)
7.3 Europe Pharmacokinetic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pharmacokinetic Testing by Region (2021-2026)
8.2 Middle East & Africa Pharmacokinetic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Pharmacokinetic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHARMACOKINETIC TESTING MARKET FORECAST

10.1 Global Pharmacokinetic Testing Forecast by Region (2027-2032)
  10.1.1 Global Pharmacokinetic Testing Forecast by Region (2027-2032)
  10.1.2 Americas Pharmacokinetic Testing Forecast
  10.1.3 APAC Pharmacokinetic Testing Forecast
  10.1.4 Europe Pharmacokinetic Testing Forecast
  10.1.5 Middle East & Africa Pharmacokinetic Testing Forecast
10.2 Americas Pharmacokinetic Testing Forecast by Country (2027-2032)
  10.2.1 United States Market Pharmacokinetic Testing Forecast
  10.2.2 Canada Market Pharmacokinetic Testing Forecast
  10.2.3 Mexico Market Pharmacokinetic Testing Forecast
  10.2.4 Brazil Market Pharmacokinetic Testing Forecast
10.3 APAC Pharmacokinetic Testing Forecast by Region (2027-2032)
  10.3.1 China Pharmacokinetic Testing Market Forecast
  10.3.2 Japan Market Pharmacokinetic Testing Forecast
  10.3.3 Korea Market Pharmacokinetic Testing Forecast
  10.3.4 Southeast Asia Market Pharmacokinetic Testing Forecast
  10.3.5 India Market Pharmacokinetic Testing Forecast
  10.3.6 Australia Market Pharmacokinetic Testing Forecast
10.4 Europe Pharmacokinetic Testing Forecast by Country (2027-2032)
  10.4.1 Germany Market Pharmacokinetic Testing Forecast
  10.4.2 France Market Pharmacokinetic Testing Forecast
  10.4.3 UK Market Pharmacokinetic Testing Forecast
  10.4.4 Italy Market Pharmacokinetic Testing Forecast
  10.4.5 Russia Market Pharmacokinetic Testing Forecast
10.5 Middle East & Africa Pharmacokinetic Testing Forecast by Region (2027-2032)
  10.5.1 Egypt Market Pharmacokinetic Testing Forecast
  10.5.2 South Africa Market Pharmacokinetic Testing Forecast
  10.5.3 Israel Market Pharmacokinetic Testing Forecast
  10.5.4 Turkey Market Pharmacokinetic Testing Forecast
10.6 Global Pharmacokinetic Testing Forecast by Type (2027-2032)
10.7 Global Pharmacokinetic Testing Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Pharmacokinetic Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pharmaceutical Product Development, LLC
  11.1.1 Pharmaceutical Product Development, LLC Company Information
  11.1.2 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Offered
  11.1.3 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Pharmaceutical Product Development, LLC Main Business Overview
  11.1.5 Pharmaceutical Product Development, LLC Latest Developments
11.2 Charles River Laboratories International, Inc.
  11.2.1 Charles River Laboratories International, Inc. Company Information
  11.2.2 Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Offered
  11.2.3 Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Charles River Laboratories International, Inc. Main Business Overview
  11.2.5 Charles River Laboratories International, Inc. Latest Developments
11.3 Creative Bioarray
  11.3.1 Creative Bioarray Company Information
  11.3.2 Creative Bioarray Pharmacokinetic Testing Product Offered
  11.3.3 Creative Bioarray Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Creative Bioarray Main Business Overview
  11.3.5 Creative Bioarray Latest Developments
11.4 Certara, L.P.
  11.4.1 Certara, L.P. Company Information
  11.4.2 Certara, L.P. Pharmacokinetic Testing Product Offered
  11.4.3 Certara, L.P. Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Certara, L.P. Main Business Overview
  11.4.5 Certara, L.P. Latest Developments
11.5 Evotec AG
  11.5.1 Evotec AG Company Information
  11.5.2 Evotec AG Pharmacokinetic Testing Product Offered
  11.5.3 Evotec AG Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Evotec AG Main Business Overview
  11.5.5 Evotec AG Latest Developments
11.6 Pacific BioLabs
  11.6.1 Pacific BioLabs Company Information
  11.6.2 Pacific BioLabs Pharmacokinetic Testing Product Offered
  11.6.3 Pacific BioLabs Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Pacific BioLabs Main Business Overview
  11.6.5 Pacific BioLabs Latest Developments
11.7 GVK Biosciences Private Limited
  11.7.1 GVK Biosciences Private Limited Company Information
  11.7.2 GVK Biosciences Private Limited Pharmacokinetic Testing Product Offered
  11.7.3 GVK Biosciences Private Limited Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 GVK Biosciences Private Limited Main Business Overview
  11.7.5 GVK Biosciences Private Limited Latest Developments
11.8 SGS SA
  11.8.1 SGS SA Company Information
  11.8.2 SGS SA Pharmacokinetic Testing Product Offered
  11.8.3 SGS SA Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 SGS SA Main Business Overview
  11.8.5 SGS SA Latest Developments
11.9 LGC Limited
  11.9.1 LGC Limited Company Information
  11.9.2 LGC Limited Pharmacokinetic Testing Product Offered
  11.9.3 LGC Limited Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 LGC Limited Main Business Overview
  11.9.5 LGC Limited Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Pharmacokinetic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pharmacokinetic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Dissolution Testing (FDC)
Table 4. Major Players of Intravenous Titration Test (IVRT)
Table 5. Major Players of Cell Line In-house Testing (ICR)
Table 6. Pharmacokinetic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Pharmacokinetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Pharmacokinetic Testing Market Size Market Share by Type (2021-2026)
Table 9. Pharmacokinetic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Pharmacokinetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Pharmacokinetic Testing Market Size Market Share by Application (2021-2026)
Table 12. Global Pharmacokinetic Testing Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Pharmacokinetic Testing Revenue Market Share by Player (2021-2026)
Table 14. Pharmacokinetic Testing Key Players Head office and Products Offered
Table 15. Pharmacokinetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmacokinetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Pharmacokinetic Testing Market Size Market Share by Region (2021-2026)
Table 20. Global Pharmacokinetic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Pharmacokinetic Testing Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Pharmacokinetic Testing Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Pharmacokinetic Testing Market Size Market Share by Country (2021-2026)
Table 24. Americas Pharmacokinetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Pharmacokinetic Testing Market Size Market Share by Type (2021-2026)
Table 26. Americas Pharmacokinetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Pharmacokinetic Testing Market Size Market Share by Application (2021-2026)
Table 28. APAC Pharmacokinetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Pharmacokinetic Testing Market Size Market Share by Region (2021-2026)
Table 30. APAC Pharmacokinetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Pharmacokinetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Pharmacokinetic Testing Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Pharmacokinetic Testing Market Size Market Share by Country (2021-2026)
Table 34. Europe Pharmacokinetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Pharmacokinetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Pharmacokinetic Testing Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pharmacokinetic Testing Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Pharmacokinetic Testing Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Pharmacokinetic Testing
Table 40. Key Market Challenges & Risks of Pharmacokinetic Testing
Table 41. Key Industry Trends of Pharmacokinetic Testing
Table 42. Global Pharmacokinetic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Pharmacokinetic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Pharmacokinetic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Pharmacokinetic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Pharmaceutical Product Development, LLC Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 47. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Offered
Table 48. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Pharmaceutical Product Development, LLC Main Business
Table 50. Pharmaceutical Product Development, LLC Latest Developments
Table 51. Charles River Laboratories International, Inc. Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 52. Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Offered
Table 53. Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Charles River Laboratories International, Inc. Main Business
Table 55. Charles River Laboratories International, Inc. Latest Developments
Table 56. Creative Bioarray Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 57. Creative Bioarray Pharmacokinetic Testing Product Offered
Table 58. Creative Bioarray Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Creative Bioarray Main Business
Table 60. Creative Bioarray Latest Developments
Table 61. Certara, L.P. Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 62. Certara, L.P. Pharmacokinetic Testing Product Offered
Table 63. Certara, L.P. Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Certara, L.P. Main Business
Table 65. Certara, L.P. Latest Developments
Table 66. Evotec AG Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 67. Evotec AG Pharmacokinetic Testing Product Offered
Table 68. Evotec AG Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Evotec AG Main Business
Table 70. Evotec AG Latest Developments
Table 71. Pacific BioLabs Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 72. Pacific BioLabs Pharmacokinetic Testing Product Offered
Table 73. Pacific BioLabs Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Pacific BioLabs Main Business
Table 75. Pacific BioLabs Latest Developments
Table 76. GVK Biosciences Private Limited Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 77. GVK Biosciences Private Limited Pharmacokinetic Testing Product Offered
Table 78. GVK Biosciences Private Limited Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. GVK Biosciences Private Limited Main Business
Table 80. GVK Biosciences Private Limited Latest Developments
Table 81. SGS SA Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 82. SGS SA Pharmacokinetic Testing Product Offered
Table 83. SGS SA Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. SGS SA Main Business
Table 85. SGS SA Latest Developments
Table 86. LGC Limited Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 87. LGC Limited Pharmacokinetic Testing Product Offered
Table 88. LGC Limited Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. LGC Limited Main Business
Table 90. LGC Limited Latest Developments

LIST OF FIGURES

Figure 1. Pharmacokinetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacokinetic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pharmacokinetic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pharmacokinetic Testing Sales Market Share by Country/Region (2025)
Figure 8. Pharmacokinetic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pharmacokinetic Testing Market Size Market Share by Type in 2025
Figure 10. Pharmacokinetic Testing in Hospital
Figure 11. Global Pharmacokinetic Testing Market: Hospital (2021-2026) & ($ millions)
Figure 12. Pharmacokinetic Testing in Clinic
Figure 13. Global Pharmacokinetic Testing Market: Clinic (2021-2026) & ($ millions)
Figure 14. Pharmacokinetic Testing in Research Institutions
Figure 15. Global Pharmacokinetic Testing Market: Research Institutions (2021-2026) & ($ millions)
Figure 16. Global Pharmacokinetic Testing Market Size Market Share by Application in 2025
Figure 17. Global Pharmacokinetic Testing Revenue Market Share by Player in 2025
Figure 18. Global Pharmacokinetic Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Pharmacokinetic Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Pharmacokinetic Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Pharmacokinetic Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Pharmacokinetic Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Pharmacokinetic Testing Value Market Share by Country in 2025
Figure 24. United States Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Pharmacokinetic Testing Market Size Market Share by Region in 2025
Figure 29. APAC Pharmacokinetic Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Pharmacokinetic Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Pharmacokinetic Testing Market Size Market Share by Country in 2025
Figure 38. Europe Pharmacokinetic Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Pharmacokinetic Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Pharmacokinetic Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Pharmacokinetic Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Pharmacokinetic Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Pharmacokinetic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 61. China Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 65. India Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 68. France Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Pharmacokinetic Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Pharmacokinetic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Pharmacokinetic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Pharmacokinetic Testing Market Size 2027-2032 ($ millions)